Literature DB >> 12959442

Transcriptional profiling of medulloblastoma in children.

Paul C Park1, Michael D Taylor, Todd G Mainprize, Laurence E Becker, Michael Ho, Wieslaw T Dura, Jeremy Squire, James T Rutka.   

Abstract

OBJECT: Although medulloblastoma is the most common malignant brain tumor found in children, little is known about its molecular pathogenesis. The authors have attempted to compare patterns of gene expression in medulloblastoma samples with those in the healthy cerebellum.
METHODS: The authors used complementary (c)DNA microarray analysis to compare the expression of genes in samples of medulloblastoma and normal cerebellum. The expression levels of a subset of genes were then verified by immunohistochemical analysis. Six genes were identified that were expressed at a much higher level in at least five of six medulloblastomas: ezrin, cyclin D2, high mobility group protein 2, MAPRE1, histone deacetylase 2, and ornithine decarboxylase 1. A number of potentially important genes whose expression was much lower in medulloblastomas than in control cerebellum were also identified: tenascin R, TRK-B, FGF receptor, and death receptor 3. The expression levels of a subset of the identified genes were confirmed by immunohistochemical analysis, which was performed on fetal cerebellum and medulloblastoma samples.
CONCLUSIONS: The authors demonstrate that cDNA microarray analysis is an effective method of increasing understanding of the molecular biology of medulloblastomas found in children. A comparison between gene expression patterns in medulloblastoma and those observed in healthy cerebellum may provide clues as to the origin of these tumors and may lead to the identification of new genes or pathways to be targeted for future therapies.

Entities:  

Mesh:

Year:  2003        PMID: 12959442     DOI: 10.3171/jns.2003.99.3.0534

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

Review 1.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

Review 2.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  Differentially Expressed Long Non-Coding RNAs Were Predicted to Be Involved in the Control of Signaling Pathways in Pediatric Astrocytoma.

Authors:  Ruth Ruiz Esparza-Garrido; Juan Manuel Rodríguez-Corona; Javier Enrique López-Aguilar; Marco Antonio Rodríguez-Florido; Ana Claudia Velázquez-Wong; Rubí Viedma-Rodríguez; Fabio Salamanca-Gómez; Miguel Ángel Velázquez-Flores
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

4.  Expression of the cytoskeleton linker protein ezrin in human cancers.

Authors:  Benjamin Bruce; Gaurav Khanna; Ling Ren; Goran Landberg; Karin Jirström; Charles Powell; Alain Borczuk; Evan T Keller; Kirk J Wojno; Paul Meltzer; Kristin Baird; Andrea McClatchey; Anthony Bretscher; Stephen M Hewitt; Chand Khanna
Journal:  Clin Exp Metastasis       Date:  2007-03-17       Impact factor: 5.150

Review 5.  Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment.

Authors:  Stephen H Settle; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

Review 6.  Role of tenascins in the ECM of gliomas.

Authors:  Nicole Brösicke; Andreas Faissner
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

7.  XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice.

Authors:  Catherine T Yan; Dhruv Kaushal; Michael Murphy; Yu Zhang; Abhishek Datta; Changzhong Chen; Brianna Monroe; Gustavo Mostoslavsky; Kristen Coakley; Yijie Gao; Kevin D Mills; Alex P Fazeli; Suprawee Tepsuporn; Giles Hall; Richard Mulligan; Edward Fox; Roderick Bronson; Umberto De Girolami; Charles Lee; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-02       Impact factor: 11.205

8.  The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.

Authors:  Hirokatsu Osawa; Christian A Smith; Young Shin Ra; Paul Kongkham; James T Rutka
Journal:  Neuro Oncol       Date:  2008-12-16       Impact factor: 12.300

9.  An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma.

Authors:  Enrico De Smaele; Caterina Fragomeli; Elisabetta Ferretti; Marianna Pelloni; Agnese Po; Gianluca Canettieri; Sonia Coni; Lucia Di Marcotullio; Azzura Greco; Marta Moretti; Concezio Di Rocco; Simona Pazzaglia; Marella Maroder; Isabella Screpanti; Giuseppe Giannini; Alberto Gulino
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

Review 10.  The clinical implications of medulloblastoma subgroups.

Authors:  Paul A Northcott; Andrey Korshunov; Stefan M Pfister; Michael D Taylor
Journal:  Nat Rev Neurol       Date:  2012-05-08       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.